Linde AG / Preliminary announcement on the disclosure of financial statements 11.12.2014 10:30 Announcement according to articles 37v, 37w, 37x ff. WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Linde AG hereby announces that the following financial reports shall be disclosed : Report: Annual financial report Date of disclosure / German: March 16, 2015 Date of disclosure / English: March 16, 2015 German: http://www.the-linde-group.com/de/investor_re...tions/inde x.html English: http://www.the-linde-group.com/de/investor_re...tions/inde x.html Report: Annual financial report of the group Date of disclosure / German: March 16, 2015 Date of disclosure / English: March 16, 2015 German: http://www.the-linde-group.com/de/investor_re...tions/inde x.html English: http://www.the-linde-group.com/de/investor_re...tions/inde x.html 11.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Linde AG KlosterhofstraÃe 1 80331 München Germany Internet: www.linde.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-AFR: Linde AG: Announcement according to Articles 37v,
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Important Legal Opportunity for Coinbase Investors in Class Action
Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...
Continue Reading
BridGene Biosciences Secures $28 Million for Drug Development
BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...
Continue Reading
NMD Pharma Breaks Ground with NMD670 in Rare Neuromuscular Treatment
NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...
Continue Reading
Becker Milk Company Limited Announces Half-Year Financial Overview
Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...
Continue Reading
Mini Melts Collaborates with 7-Eleven for Blue Raspberry Flavor
Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...
Continue Reading